Palvella Therapeutics Inc
(PVLA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 46,279 | 29,101 | 25,275 | 5,831 | 2,932 |
| Gross Profit | 46,279 | 29,101 | 25,275 | 5,831 | 2,932 |
| Operating Expenses | 73,436 | 59,932 | 39,869 | 28,590 | 16,613 |
| Operating Income | -27,157 | -30,831 | -14,594 | -22,759 | -13,681 |
| Interest Expense | 0 | 0 | -152 | -2 | 185 |
| Other Income | 1,688 | 3,765 | -2,102 | 120 | 11 |
| Pre-tax Income | -25,469 | -27,066 | -16,544 | -22,637 | -13,855 |
| Income Tax | N/A | -312 | 1,103 | 162 | 204 |
| Net Income Continuous | -25,469 | -26,754 | -17,647 | -22,799 | -14,059 |
| Net Income | $-25,469 | $-26,754 | $-17,647 | $-22,799 | $-14,059 |
| EPS Basic Total Ops | -44.80 | -40.00 | -32.00 | -44.00 | -32.80 |
| EPS Basic Continuous Ops | -40.25 | -40.32 | -32.14 | -43.73 | -32.70 |
| EPS Diluted Total Ops | -44.80 | -40.00 | -32.00 | -44.00 | -32.80 |
| EPS Diluted Continuous Ops | -40.25 | -40.32 | -32.14 | -43.73 | -32.70 |
| EPS Diluted Before Non-Recurring Items | -44.80 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-26,525 | $-30,261 | $-14,225 | $-22,398 | $-13,373 |